Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss

od Bogina, Giuseppe, Bortesi, Laura, Marconi, Marcella, Venturini, Marco, Lunardi, Gianluigi, Coati, Francesca, Massocco, Alberto, Manfrin, Erminia, Pegoraro, Cristina, Zamboni, Giuseppe
Izdano 2011

Potentiation of Topoisomerase I and II Inhibitors Cell Killing by Tumor Necrosis Factor: Relationship to DNA Strand Breakage Formation

od Orengo, Giorgia, Noviello, Elvira, Cimoli, Guido, Pagnan, Gabriella, Parodi, Silvio, Venturini, Marco, Conte, Pier Franco, Schenone, Federico, Conzi, Gianfranco, Russo, Patrizia
izdano v Jpn J Cancer Res (1992)

HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients

od Del Mastro, L, Bruzzi, P, Nicolò, G, Cavazzini, G, Contu, A, D'Amico, M, Lavarello, A, Testore, F, Castagneto, B, Aitini, E, Perdelli, L, Bighin, C, Rosso, R, Venturini, Marco
Izdano 2005

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

od Gori, Stefania, Clavarezza, Matteo, Siena, Salvatore, Foglietta, Jennifer, Tarenzi, Emiliana, Giordano, Monica, Molino, Annamaria, Graiff, Claudio, Fusco, Vittorio, Alabiso, Oscar, Baldini, Editta, Gamucci, Teresa, Altavilla, Giuseppe, Dondi, Davide, Venturini, Marco
Izdano 2012

Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial

od Bedognetti, Davide, Sertoli, Mario Roberto, Pronzato, Paolo, Del Mastro, Lucia, Venturini, Marco, Taveggia, Paola, Zanardi, Elisa, Siffredi, Guido, Pastorino, Simona, Queirolo, Paola, Gardin, Giovanni, Wang, Ena, Monzeglio, Clara, Boccardo, Francesco, Bruzzi, Paolo
Izdano 2011

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

od Clavarezza, Matteo, Mustacchi, Giorgio, Casadei Gardini, Andrea, Del Mastro, Lucia, De Matteis, Andrea, Riccardi, Ferdinando, Adamo, Vincenzo, Aitini, Enrico, Amoroso, Domenico, Marchetti, Paolo, Gori, Stefania, Carrozza, Francesco, Maiello, Evaristo, Giotta, Francesco, Dondi, Davide, Venturini, Marco
Izdano 2012

Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of dif...

od Del Mastro, Lucia, Fabi, Alessandra, Mansutti, Mauro, De Laurentiis, Michele, Durando, Antonio, Merlo, Domenico Franco, Bruzzi, Paolo, La Torre, Ignazia, Ceccarelli, Matteo, Kazeem, Gbenga, Marchi, Paolo, Boy, Davide, Venturini, Marco, De Placido, Sabino, Cognetti, Francesco
Izdano 2013

Improving Quality in Nanoparticle-Induced Cytotoxicity Testing by a Tiered Inter-Laboratory Comparison Study

od Nelissen, Inge, Haase, Andrea, Anguissola, Sergio, Rocks, Louise, Jacobs, An, Willems, Hanny, Riebeling, Christian, Luch, Andreas, Piret, Jean-Pascal, Toussaint, Olivier, Trouiller, Bénédicte, Lacroix, Ghislaine, Gutleb, Arno C., Contal, Servane, Diabaté, Silvia, Weiss, Carsten, Lozano-Fernández, Tamara, González-Fernández, África, Dusinska, Maria, Huk, Anna, Stone, Vicki, Kanase, Nilesh, Nocuń, Marek, Stępnik, Maciej, Meschini, Stefania, Ammendolia, Maria Grazia, Lewinski, Nastassja, Riediker, Michael, Venturini, Marco, Benetti, Federico, Topinka, Jan, Brzicova, Tana, Milani, Silvia, Rädler, Joachim, Salvati, Anna, Dawson, Kenneth A.
izdano v Nanomaterials (Basel) (2020)